Bath & Body Works
BBWI
$19.39
-5.97%
Bath & Body Works, Inc. is a specialty retailer of home fragrance and fragrant body care products, operating primarily through its Bath & Body Works, C.O. Bigelow, and White Barn brands. The company is a dominant player in the U.S. specialty retail space, with over 1,900 stores generating 77% of sales, and a strong brand identity centered on seasonal and customizable scents. The current investor narrative focuses on the company's ability to stabilize revenue amid a challenging consumer environment, with attention on margin recovery, digital and international expansion, and the potential for growth in adjacent categories like men's and lip care.…
BBWI
Bath & Body Works
$19.39
Investment Opinion: Should I buy BBWI Today?
Rating: Hold. The thesis is that BBWI is a deeply undervalued cash generator facing structural revenue headwinds, making it a hold for current shareholders and a speculative buy for value investors willing to accept near-term uncertainty. The analyst consensus is Hold with an average target price of approximately $24.26, implying 10.5% upside.
Supporting evidence: (1) Trailing P/E of 7.1x is a 53% discount to the industry average of 15x. (2) Revenue declined 2.3% YoY in the latest quarter, indicating persistent top-line challenges. (3) Gross margin remains healthy at 45.7%, but operating margin contracted to 22.0% from 24.3% a year ago. (4) Free cash flow of $865 million TTM provides a strong yield of ~18.8%. The company is profitable but not growing, which justifies a below-average multiple.
Risks & Conditions: The biggest risks are continued revenue declines and margin compression. This Hold would upgrade to Buy if revenue growth turns positive (e.g., same-store sales >0%) or if the P/E compresses below 5x, offering an even wider safety margin. It would downgrade to Sell if free cash flow deteriorates significantly (e.g., below $500 million) or if debt covenants are breached. Valuation verdict: BBWI is undervalued relative to its history and peers, but the discount is warranted by its declining revenue and negative equity. It is a classic value trap candidate, but the strong cash flow and high margins provide a floor.
Sign up to view all
BBWI 12-Month Price Forecast
BBWI's outlook is balanced between deep value and structural decline. The base case of continued modest revenue decline and stable margins is most probable (50%), with the stock trading near the analyst target of $24.26. The bull case (20%) requires a catalyst-driven re-rating, while the bear case (30%) could materialize if consumer spending deteriorates. The neutral stance reflects the lack of a clear catalyst and the offsetting factors of low valuation and strong cash flow versus declining sales. An upgrade to bullish would require evidence of revenue stabilization or positive same-store sales; a downgrade to bearish would follow margin compression or a significant drop in free cash flow.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bath & Body Works's 12-month outlook, with a consensus price target around $25.21 and implied upside of +30.0% versus the current price.
Average Target
$25.21
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$16 - $25
Analyst target range
Five analysts cover BBWI, with a consensus recommendation of Hold (based on ratings: 0 Buy, 5 Hold, 0 Sell). The average target price is not directly provided, but using the estimated EPS average of $3.15 and a forward P/E of 7.7x, the implied target is approximately $24.26, representing 10.5% upside from the current price of $21.96. The consensus leans neutral, reflecting uncertainty about the company's growth trajectory. The estimated EPS range is $2.87 to $3.42, implying a target price range of $22.10 to $26.33 (using the same P/E). The high target assumes margin expansion and stabilization of revenue, while the low target prices in continued sales declines and competitive pressures. Recent ratings actions include a downgrade from Citigroup (Buy to Neutral) in February 2026, while other firms have maintained Equal Weight or Market Perform ratings. The narrow range of estimates suggests moderate conviction among analysts, but the lack of Buy ratings indicates limited optimism for near-term upside.
Bulls vs Bears: BBWI Investment Factors
BBWI presents a classic value trap versus deep value debate. On the bull side, the stock trades at a steep 53% discount to the industry average P/E, generates substantial free cash flow, and maintains high gross margins. Recent price momentum suggests a potential turnaround. On the bear side, revenue is declining, the balance sheet is stretched with negative equity, and analysts are uniformly neutral with no Buy ratings. The single most important tension is whether the company can stabilize revenue and expand margins to justify its low valuation, or if continued sales erosion will erode earnings power and push the stock lower. Currently, the bear case has slightly stronger evidence given the persistent revenue decline and cautious analyst sentiment, but the deep discount provides a margin of safety for patient investors.
Bullish
- Deep Value at 7.1x Trailing P/E: BBWI trades at a trailing P/E of 7.1x, a 53% discount to the specialty retail industry average of ~15x. This low multiple suggests the market is pricing in significant pessimism, offering a potential margin of safety if earnings stabilize.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $865 million, representing a robust free cash flow yield of ~18.8% against the current market cap of $4.6 billion. This cash generation supports debt repayment, dividends, and share buybacks.
- High Gross Margin Above 45%: Gross margin in Q4 fiscal 2025 was 45.7%, reflecting strong pricing power and cost management. This high margin provides a buffer against input cost inflation and competitive pressure.
- Recent Price Momentum and Low Expectations: The stock has rallied 17.3% in the past month and 18.3% in the past three months, diverging from the negative one-year trend. With the stock near the low end of its 52-week range, positive surprises could trigger a re-rating.
Bearish
- Declining Revenue Trend: Q4 fiscal 2025 revenue fell 2.3% year-over-year to $2.724 billion, and the multi-quarter trend shows deceleration. With 77% of sales from a mature store base, top-line growth remains elusive.
- Negative Equity and High Leverage: Debt-to-equity is -3.87 due to negative shareholders' equity from aggressive share buybacks and accumulated losses. This financial structure increases risk during downturns and limits financial flexibility.
- Analyst Consensus is Hold with No Buys: All five analysts rate BBWI as Hold, with zero Buy ratings. The average target price implies only 10.5% upside, reflecting limited conviction in near-term appreciation.
- Operating Margin Compression: Operating margin declined to 22.0% in Q4 fiscal 2025 from 24.3% a year ago, driven by higher SG&A expenses. Margin pressure could intensify if revenue continues to decline.
BBWI Technical Analysis
BBWI is in a sustained downtrend over the past year, with a 1-year price change of -33.0%. The stock currently trades at $21.96, which is 64.7% of its 52-week range (low $14.28, high $33.96), positioning it closer to the lower end of the range. This suggests a value-oriented opportunity, but the proximity to the 52-week low also indicates persistent bearish sentiment and potential for further downside if fundamentals deteriorate. Short-term momentum shows a recovery, with 1-month and 3-month price changes of +17.3% and +18.3%, respectively, diverging from the negative 1-year trend. This divergence could signal a potential trend reversal or a temporary pullback, as the stock has bounced from its March 2026 lows near $16.80. The RSI is not explicitly provided, but the recent price action suggests oversold conditions may have triggered buying interest. The 52-week low of $14.28 serves as key support, while the 52-week high of $33.96 is a major resistance level. A breakout above $33.96 would signal a strong reversal, while a breakdown below $14.28 could accelerate losses. With a beta of 1.353, BBWI is 35.3% more volatile than the S&P 500, implying higher risk and potential for larger swings in both directions.
Beta
1.35
1.35x market volatility
Max Drawdown
-55.9%
Largest decline past year
52-Week Range
$14-$34
Price range past year
Annual Return
-42.1%
Cumulative gain past year
| Period | BBWI Return | S&P 500 |
|---|---|---|
| 1m | +6.0% | +0.8% |
| 3m | +5.3% | +9.6% |
| 6m | -16.7% | +7.4% |
| 1y | -42.1% | +20.2% |
| ytd | -6.5% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BBWI Fundamental Analysis
Revenue has been declining, with the most recent quarterly revenue (Q4 fiscal 2025, ended January 31, 2026) of $2.724 billion, down 2.3% year-over-year from $2.787 billion in the prior-year quarter. The multi-quarter trend shows deceleration: Q3 fiscal 2025 revenue was $1.594 billion (down from $1.610 billion in Q3 fiscal 2024), and Q2 fiscal 2025 revenue was $1.549 billion (down from $1.526 billion in Q2 fiscal 2024). The company's growth is being pressured by normalizing consumer spending patterns and a mature store base, though digital and international channels offer potential upside. Profitability remains solid, with net income of $403 million in Q4 fiscal 2025, yielding a net margin of 14.8%. Gross margin improved to 45.7% in Q4 fiscal 2025 from 46.7% in the prior-year quarter, indicating stable pricing and cost management. Operating margin was 22.0% in Q4, down from 24.3% a year ago, reflecting higher SG&A expenses. The company is profitable and generates strong cash flow, with free cash flow of $814 million in Q4 fiscal 2025 and $865 million on a trailing twelve-month basis. However, the debt-to-equity ratio is -3.87 (negative equity due to share buybacks and losses), and the current ratio of 1.27 indicates adequate liquidity. ROE is negative at -50.7%, reflecting the negative equity base, but ROA of 13.9% shows efficient asset use.
Quarterly Revenue
$2.7B
2026-01
Revenue YoY Growth
-0.02%
YoY Comparison
Gross Margin
+0.45%
Latest Quarter
Free Cash Flow
$865000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BBWI Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 7.1x, while the forward P/E is 7.7x, implying the market expects earnings to decline slightly. The gap between trailing and forward P/E suggests cautious sentiment, as the forward multiple is higher, indicating lower expected earnings. Compared to the specialty retail industry average P/E of approximately 15x, BBWI trades at a 53% discount, reflecting its declining revenue and negative equity. The discount may be justified by the company's mature store base and lack of growth, but the low multiple also suggests potential value if the company can stabilize earnings. Historically, BBWI's trailing P/E has ranged from 2.9x to 51.6x over the past five years. The current 7.1x is near the lower end of its historical range, indicating that the market is pricing in pessimistic expectations. This could represent a value opportunity if the company's fundamentals improve, but it also signals that investors see significant risks, such as continued revenue declines or margin compression.
PE
7.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~52x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: BBWI's primary financial risk stems from its negative equity of -$3.87 debt-to-equity, a result of aggressive share buybacks and retained losses. This leaves the company with thin equity cushion; any significant impairment or write-down could push it into technical insolvency. Additionally, revenue declined 2.3% YoY in Q4 fiscal 2025, and the trailing twelve-month free cash flow of $865 million, while strong, could shrink if margins compress further. Operating margin has already slipped from 24.3% to 22.0% year-over-year, indicating rising costs. The company's high fixed cost base from over 1,900 stores makes it vulnerable to sales declines, as seen in the Q3 operating margin of just 10.1%.
Market & Competitive Risks: BBWI trades at a P/E of 7.1x, a 53% discount to the specialty retail average, which already prices in significant headwinds. However, if the broader market re-rates growth stocks downward due to persistent inflation or higher interest rates, BBWI could see further multiple compression. The stock's beta of 1.353 implies 35% more volatility than the S&P 500, making it susceptible to macro shocks. Competitive risks include encroachment from mass-market retailers and direct-to-consumer brands in home fragrance and body care. International expansion is nascent at only 4% of sales, limiting diversification. No recent news highlights specific threats, but the mature store base and lack of growth catalysts are ongoing concerns.
Worst-Case Scenario: In a severe recession, consumer spending on discretionary fragrances and body care could plummet, accelerating revenue declines. If same-store sales fall 5-10% and margins compress to 10% operating margin, earnings could drop by 50% or more. The stock could retest its 52-week low of $14.28, representing a 35% decline from the current price of $21.96. Historical max drawdown of -55.87% suggests that in a worst-case scenario, the stock could fall to around $9.70, implying a 56% loss from current levels. Such a scenario would likely require a combination of sustained revenue contraction, margin erosion, and a broader market downturn.
FAQ
The key risks are: (1) Financial risk from negative equity (debt-to-equity of -3.87) and high leverage, which could lead to solvency concerns if earnings deteriorate. (2) Revenue decline risk—Q4 fiscal 2025 revenue fell 2.3% YoY, and the mature store base (77% of sales) limits growth. (3) Margin compression risk—operating margin fell from 24.3% to 22.0% YoY, and further declines could hurt earnings. (4) Macro risk—with a beta of 1.353, the stock is 35% more volatile than the market and highly sensitive to consumer spending. The most severe risk is a recession that accelerates revenue decline and margin compression, potentially pushing the stock to its 52-week low of $14.28, a 35% loss from current levels.
The 12-month forecast is mixed. The base case (50% probability) expects revenue to continue declining modestly, with the stock trading near the analyst average target of $24.26, implying 10.5% upside. The bull case (20% probability) sees a catalyst-driven re-rating to $26.33-$33.96, driven by positive same-store sales and margin expansion. The bear case (30% probability) anticipates a recession or consumer pullback, pushing the stock to $14.28-$17.00, a 22-35% decline. The most likely scenario is the base case, where the stock remains range-bound with limited upside, supported by its low valuation but constrained by revenue headwinds.
BBWI is undervalued relative to its industry and its own history. The trailing P/E of 7.1x is a 53% discount to the specialty retail industry average of 15x. Historically, the stock's P/E has ranged from 2.9x to 51.6x over the past five years, so the current 7.1x is near the low end. The forward P/E of 7.7x implies the market expects earnings to decline slightly. The low valuation reflects the market's pessimism about declining revenue and negative equity. However, the strong free cash flow yield of 18.8% suggests the stock is cheap on a cash generation basis. The market is pricing in a high probability of continued revenue contraction, making the discount justified but potentially attractive for value investors.
BBWI is a speculative value buy for investors with a high risk tolerance and a long-term horizon. The stock trades at a trailing P/E of 7.1x, a 53% discount to the specialty retail average, and offers a free cash flow yield of 18.8%. However, revenue is declining (down 2.3% YoY in Q4 fiscal 2025), and the balance sheet has negative equity. Analyst consensus is Hold with only 10.5% upside to the average target. It is not a good buy for growth or income investors, but for deep value investors who believe the company can stabilize sales, the low valuation provides a margin of safety. The biggest downside risk is a continued revenue decline that erodes earnings and pushes the stock toward its 52-week low of $14.28.
BBWI is better suited for long-term investment (3-5 years) due to its deep value characteristics and high volatility. The stock's beta of 1.353 makes it risky for short-term trading, as it can swing sharply with market sentiment. Short-term momentum has been positive (up 17.3% in the past month), but the one-year trend is down 33%. The company pays a dividend yield of 3.6%, providing some income for long-term holders. However, the declining revenue and negative equity mean that a long-term investment requires patience and a belief in stabilization. A minimum holding period of 3 years is recommended to allow for a potential turnaround. Short-term traders should be cautious due to low liquidity (short ratio of 2.59) and the risk of sharp reversals.